These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1059362)

  • 1. Occurrence of deaminated monophosphate nucleotide in extracellular sites after giving arabinofuranosylcytosine or deoxycytidine to mice.
    Chou TC; Hutchison DJ; Schmid FA; Philips FS
    Ann N Y Acad Sci; 1975 Aug; 255():287-91. PubMed ID: 1059362
    [No Abstract]   [Full Text] [Related]  

  • 2. Deoxycytidine kinase. I. Distribution in normal and neoplastic tissues and interrelationships of deoxycytidine and 1-beta-D-arabinofuranosylcytosine phosphorylation.
    Durham JP; Ives DH
    Mol Pharmacol; 1969 Jul; 5(4):358-75. PubMed ID: 4308509
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhancement of 1-beta-D-arabinofuranosylcytosine accumulation within L1210 cells and increased cytotoxicity following thymidine exposure.
    Grant S; Lehman C; Cadman E
    Cancer Res; 1980 May; 40(5):1525-31. PubMed ID: 7370990
    [No Abstract]   [Full Text] [Related]  

  • 4. Transport of two non-metabolized nucleosides, deoxycytidine and cytosine arabinoside, in a sub-line of the L1210 murine leukemia.
    Kessel D; Shurin SB
    Biochim Biophys Acta; 1968 Sep; 163(2):179-87. PubMed ID: 5686275
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism of 1-beta-D-arabinofuranosylcytosine in leukemia L1210: studies with intact cells.
    Shrecker AW; Urshel MJ
    Cancer Res; 1968 Apr; 28(4):793-801. PubMed ID: 5649066
    [No Abstract]   [Full Text] [Related]  

  • 6. Biochemical and genetic studies of a mutant strain of mouse leukemia L1210 resistant to 1-beta-D-arabinofuranosylcytosine (Cytarabine).
    Bach MK
    Cancer Res; 1969 May; 29(5):1036-44. PubMed ID: 5781095
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolism of 1-beta-D-arabinofuranosylcytosine in leukemia L1210: nucleoside and nucleotide kinases in cell-free extracts.
    Schrecker AW
    Cancer Res; 1970 Mar; 30(3):632-41. PubMed ID: 5425288
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolism and selective effects of 1-beta-D-arabinofuranosylcytosine in L1210 and Host tissues in vivo.
    Chou TC; Hutchinson DJ; Schmid FA; Philips FS
    Cancer Res; 1975 Jan; 35(1):225-36. PubMed ID: 1109791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of uracil derivatives on phosphorylation of arabinosylcytosine.
    Grindey GB; Saslaw LD; Waravdekar VS
    Mol Pharmacol; 1968 Jan; 4(1):96-103. PubMed ID: 5640783
    [No Abstract]   [Full Text] [Related]  

  • 10. Analogs of 1-beta-D-arabinofuranosylcytosine. Studies on mechanisms of action in Burkitt's cell culture and mouse leukemia, and in vitro deamination studies.
    Dollinger MR; Burchenal JH; Kreis W; Fox JJ
    Biochem Pharmacol; 1967 Apr; 16(4):689-706. PubMed ID: 6033789
    [No Abstract]   [Full Text] [Related]  

  • 11. Correlation of mouse tissue distribution of arabinosylcytosine in vivo with enzymatic activities in vitro.
    Ho DH
    Drug Metab Dispos; 1976; 4(3):296-300. PubMed ID: 6236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inability of liposome encapsulated 1-beta-D-arabinofuranosylcytosine nucleotides to overcome drug resistance in L1210 cells.
    Rustum YM; Mayhew E; Szoka F; Campbell J
    Eur J Cancer Clin Oncol; 1981 Jul; 17(7):809-17. PubMed ID: 7199474
    [No Abstract]   [Full Text] [Related]  

  • 13. Disposition of arabinosylcytosine (NSC-63878) and 6-THIOGUANINE (NSC-752) in solid L1210 leukemia tumor-bearing mice.
    Pittillo RF; Woolley C
    Cancer Chemother Rep; 1973; 57(3):275-89. PubMed ID: 4201593
    [No Abstract]   [Full Text] [Related]  

  • 14. The physiological disposition of 5-fluorouracil in mice bearing solid L1210 lymphocytic leukemia.
    Chadwick M; Rogers WI
    Cancer Res; 1972 May; 32(5):1045-56. PubMed ID: 4259631
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics and cellular determinants of response to 1-beta-arabinofuranosylcytosine (ara-C).
    Riva CM; Rustum YM; Preisler HD
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):1-8. PubMed ID: 3859925
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytosine arabinoside uptake by tumour cells in vitro.
    Mulder JH; Harrap KR
    Eur J Cancer (1965); 1975 May; 11(5):373-9. PubMed ID: 1171764
    [No Abstract]   [Full Text] [Related]  

  • 17. Kinetics of 5-aza-2'-deoxycytidine phosphorylation in mouse spleen and L1210 leukemic cell extracts.
    Veselý J; Cihák A
    Neoplasma; 1980; 27(2):121-7. PubMed ID: 6156420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the mode of action of 2,2'-anhydro-1- -D-arabinofuranosylcytosine.
    Wang MC; Sharma RA; Bloch A
    Cancer Res; 1973 Jun; 33(6):1265-71. PubMed ID: 4578070
    [No Abstract]   [Full Text] [Related]  

  • 19. Biochemical and pharmacological studies with 1-beta-D-arabinofuranosylcytosine in man.
    Creasey WA; Papac RJ; Markiw ME; Calabresi P; Welch AD
    Biochem Pharmacol; 1966 Oct; 15(10):1417-28. PubMed ID: 4291357
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
    Li ZR; Campbell J; Rustum YM
    Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.